Position in PCRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$699,882
+$551,310 QoQ
Shares Held
27,587
+319.6% QoQ
Ownership
0.069%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#106
of 251 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Vinva Investment Management Ltd holds $108,435,653 across 5 Drug Manufacturers - Specialty & Generic names. PCRX ranks #4 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
346,109 | $58,333,210 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
88,369 | $47,880,975 | |
| 3 | COLL |
Collegium Pharmaceutical, Inc
|
24,992 | $904,710 | |
| 4 | PCRX |
Pacira BioSciences, Inc.
This page
|
27,587 | $699,882 | |
| 5 | ANIP |
Ani Pharmaceuticals Inc
|
7,452 | $616,876 |
All Filings in PCRX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $699,882 | 27,587 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $148,572 | 6,574 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||